File Download

There are no files associated with this item.

Supplementary

Article: Kinase Inhibitors for the Treatment of Rheumatoid Arthritis

TitleKinase Inhibitors for the Treatment of Rheumatoid Arthritis
Authors
KeywordsJanus kinase
Mitogen-activated protein kinase
Protein kinase inhibitor
Rheumatoid arthritis
Spleen tyrosine kinase
Issue Date2012
PublisherThe Hong Kong Society of Rheumatology. The Journal's web site is located at http://www.rheumatology.org.hk/main.php?id=27&lang=eng
Citation
Hong Kong Bulletin on Rheumatic Diseases, 2012, v. 12 n. 2, p. 43-49 How to Cite?
AbstractThe use of biologics has been a major advance in the treatment of rheumatoid arthritis over the last decade. However, their need for a parenteral route of administration has made them less desirable for some patients. Efforts have been channelled into the development of oral tyrosine kinase inhibitors, and their results have been promising. This article will provide an overall review of three main tyrosine kinase inhibitors which have been studied for patients with rheumatoid arthritis.
Persistent Identifierhttp://hdl.handle.net/10722/189257

 

DC FieldValueLanguage
dc.contributor.authorTsang, HHLen_US
dc.contributor.authorChung, HYen_US
dc.contributor.authorMok, MYen_US
dc.contributor.authorLau, CSen_US
dc.date.accessioned2013-09-17T14:31:00Z-
dc.date.available2013-09-17T14:31:00Z-
dc.date.issued2012en_US
dc.identifier.citationHong Kong Bulletin on Rheumatic Diseases, 2012, v. 12 n. 2, p. 43-49en_US
dc.identifier.urihttp://hdl.handle.net/10722/189257-
dc.description.abstractThe use of biologics has been a major advance in the treatment of rheumatoid arthritis over the last decade. However, their need for a parenteral route of administration has made them less desirable for some patients. Efforts have been channelled into the development of oral tyrosine kinase inhibitors, and their results have been promising. This article will provide an overall review of three main tyrosine kinase inhibitors which have been studied for patients with rheumatoid arthritis.-
dc.languageengen_US
dc.publisherThe Hong Kong Society of Rheumatology. The Journal's web site is located at http://www.rheumatology.org.hk/main.php?id=27&lang=eng-
dc.relation.ispartofHong Kong Bulletin on Rheumatic Diseasesen_US
dc.subjectJanus kinase-
dc.subjectMitogen-activated protein kinase-
dc.subjectProtein kinase inhibitor-
dc.subjectRheumatoid arthritis-
dc.subjectSpleen tyrosine kinase-
dc.titleKinase Inhibitors for the Treatment of Rheumatoid Arthritisen_US
dc.typeArticleen_US
dc.identifier.emailMok, MY: temy@hkucc.hku.hken_US
dc.identifier.emailLau, CS: cslau@hku.hken_US
dc.identifier.authorityMok, TMY=rp00490en_US
dc.identifier.authorityLau, WCS=rp01348en_US
dc.identifier.hkuros223173en_US
dc.identifier.volume12en_US
dc.identifier.issue2-
dc.identifier.spage43en_US
dc.identifier.epage49en_US
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats